miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and

Tidi Hassan1, Tomás P Carroll, Patrick G Buckley

  • 11 Respiratory Research Division, Department of Medicine, and.

Abstract

Insights

MicroRNAs regulate the unfolded protein response in alpha-1 antitrypsin deficiency. Epigenetic silencing of miR-199a-5p in monocytes is linked to chronic obstructive pulmonary disease progression.

Area of Science:

  • Cellular and Molecular Biology
  • Pulmonary Medicine
  • Epigenetics

Background:

  • Alpha-1 antitrypsin (AAT) deficiency causes abnormal protein buildup, activating the unfolded protein response (UPR) in monocytes.
  • The role of microRNAs (miRNAs) in UPR and chronic obstructive pulmonary disease (COPD) pathogenesis remains unclear.

Purpose of the Study:

  • Investigate miRNA expression and function in MM and ZZ AAT-deficient monocytes.
  • Identify specific miRNAs that regulate the UPR in the context of AAT deficiency and COPD.

Main Methods:

  • Monocyte isolation from MM and ZZ individuals (asymptomatic vs. symptomatic).
  • miRNA expression profiling, pyrosequencing, quantitative PCR, and Western blotting.
  • Luciferase reporter assays to confirm miRNA-target interactions and functional studies using pre-miR/anti-miR.

Main Results:

  • Forty-three differentially expressed miRNAs identified; miR-199a-5p was significantly upregulated in asymptomatic ZZ monocytes.
  • Promoter hypermethylation of miR-199a-2 correlated with increased UPR markers (GRP78, ATF6, p50, p65) in symptomatic monocytes.
  • miR-199a-5p directly targets ATF6, p50, and p65, modulating UPR and cytokine expression.

Conclusions:

  • miR-199a-5p is a critical regulator of the UPR in AAT-deficient monocytes.
  • Epigenetic silencing of miR-199a-5p contributes to COPD pathogenesis by dysregulating the UPR.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K